Abstract
Buspirone is an anxiolytic drug with an unknown mechanism of action. We have addressed the proposal that its therapeutic effect is due to a metabolite, 1-(2-pyrimidinyl)-piperazine (1-PP), increasing the open probability of γ-aminobutyric acid (GABA)-activated channels. By making whole-cell recordings from cultured spinal neurones we demonstrated that 1-PP, in contrast to flurazepam, actually antagonizes GABA- and glycine-activated currents. These observations are inconsistent with this proposed mechanism of action for buspirone.
Original language | English (US) |
---|---|
Pages (from-to) | 366-367 |
Number of pages | 2 |
Journal | Brain research |
Volume | 493 |
Issue number | 2 |
DOIs | |
State | Published - Jul 31 1989 |
Externally published | Yes |
Keywords
- 1-(2-Pyrimidinyl)piperazine
- Benzodiazepine
- Buspirone
- Chloride channel
- Glycine
- Neuron
- Spinal cord
- γ-Aminobutyric acid
ASJC Scopus subject areas
- Neuroscience(all)
- Molecular Biology
- Clinical Neurology
- Developmental Biology